# GORE® VIABIL® Biliary Endoprosthesis in the Treatment of Benign Biliary Strictures Secondary to Chronic Pancreatitis

> **NCT05820009** · NA · SUSPENDED · sponsor: **W.L.Gore & Associates** · enrollment: 133 (estimated)

## Conditions studied

- Pancreatitis, Chronic
- Stricture; Bile Duct

## Interventions

- **DEVICE:** GORE® VIABIL® Biliary Endoprosthesis
- **DEVICE:** GORE® VIABIL® Short Wire Biliary Endoprosthesis

## Key facts

- **NCT ID:** NCT05820009
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2024-02-01
- **Primary completion:** 2026-08-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 133 (ESTIMATED)
- **Why stopped:** The Gore VIABILITY Pivotal Study is being suspended. The suspension is not due to any safety or performance concerns. No sites have been activated and no subjects have been enrolled in the study.
- **Last updated:** 2024-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05820009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05820009, "GORE® VIABIL® Biliary Endoprosthesis in the Treatment of Benign Biliary Strictures Secondary to Chronic Pancreatitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05820009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*